Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on l 1210 leukaemia and immunosuppressive effect of 4 of them.
D000470:Alkaloids / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D011725:Pyridines / Q000627:therapeutic use; D013997:Time Factors
D000470:Alkaloids; D000970:Antineoplastic Agents; D002227:Carbazoles; D007166:Immunosuppressive Agents; D011725:Pyridines